Balasis, M., Forinash, K., Chen, Y., Fulp, W., Coppola, D., Hamilton, A., . . . Sebti, S. (2011). Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.
Chicago Style (17th ed.) CitationBalasis, M., K. Forinash, Y. Chen, W. Fulp, D. Coppola, A. Hamilton, J. Cheng, and S. Sebti. Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice. 2011.
MLA (9th ed.) CitationBalasis, M., et al. Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice. 2011.
Warning: These citations may not always be 100% accurate.